Sun Pharmaceutical Industries Ltd.

NSE: SUNPHARMA | BSE: 524715 | ISIN: INE044A01036 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive
1807.4000 -24.20 (-1.32%)
NSE Dec 01, 2025 15:31 PM
Volume: 1.9M
 

logo
Sun Pharmaceutical Industries Ltd.
03 Aug 2023
1807.40
-1.32%
buy
by BOB Capital Markets Ltd.
Target: 1160
BOB Capital Markets Ltd.
Q1 revenue/EBITDA beat consensus by 2%/11%, but reported PAT missed estimates by 6% due to exceptional items
 
Number of FII/FPI investors decreased from 1326 to 1225 in Sep 2025 qtr
More from Sun Pharmaceutical Industries Ltd.
Recommended
IPO market heats up: Meesho and Aequs launch, six SME debuts on the calendar
| 01 Dec 2025, 05:15PM
Market closes flat, dragged by healthcare and realty sectors
Trendlyne Marketwatch | 01 Dec 2025, 04:14PM
Change is hard, and some Indian pharma companies are embracing it better than others
| 09 Aug 2022